Drug Profile
Tesaglitazar
Alternative Names: ARH 039242XX; ARH 39242; AZ 242; GalidaLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Alkanesulfonates; Antihyperlipidaemics; Phenylpropionates; Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Insulin resistance; Metabolic syndrome; Type 2 diabetes mellitus
Most Recent Events
- 04 May 2006 Discontinued - Phase-III for Insulin resistance (PO)
- 04 May 2006 Discontinued - Phase-III for Metabolic syndrome (PO)
- 04 May 2006 Discontinued - Phase-III for Type-2 diabetes mellitus (PO)